Malaysia’s healthcare sector continues to grow rapidly, supported by a robust regulatory environment aimed at ensuring the safety, quality, and performance of medical devices. Central to this framework is the Medical Device Act 2012 (Act 737. Under this Act, all medical devices must be registered with the Medical Device Authority (MDA) before they can be imported, exported, or marketed in Malaysia. This article outlines the full registration process, responsibilities, and regulatory requirements, based on the guidelines issued by the MDA.
Regulatory Background and Key Stakeholders
Act 737 establishes the legal framework for regulating medical devices in Malaysia. The Medical Device Authority, under the Ministry of Health, is tasked with overseeing the implementation and enforcement of the Act.
The Act defines a medical device as any instrument, apparatus, implement, machine, appliance, software, material, or other similar or related article intended for use in healthcare. These may be used for diagnosis, prevention, monitoring, treatment, or alleviation of disease or handicap — but do not include drugs.
Two parties are recognized as responsible for registering a medical device in Malaysia: the local manufacturer and, in the case of foreign-made devices, the authorized representative (local agent) of the overseas manufacturer.
Overview of the Registration Process
The Malaysia medical device registration process is carried out online via the Medical Device Centralized Online Application System (MeDC@St). Before submitting an application, the applicant must complete several preliminary steps, including classification, grouping, and conformity assessment.
- Determining Whether a Product is a Medical Device
The first step is to determine whether the product in question qualifies as a medical device under Section 2 of the Medical Device Act 2012.
- Classifying the Medical Device
Medical devices in Malaysia are categorized into four classes—Class A (lowest risk), Class B, Class C, and Class D (highest risk)—based on intended use and risk to patients.
Medical devices in Malaysia are grouped into distinct categories based on their functionality and nature:
Non-active devices:
- General devices for anesthesia, infusion, and orthopedic use
- Non-active implants (e.g., cardiovascular, orthopedic, soft tissue)
- Devices for wound care and dental procedures
Active devices:
- Equipment requiring electrical or mechanical power, such as ventilators and monitors
- Devices used in imaging, therapy, or patient monitoring
- Software considered as standalone medical devices
Active implantable medical devices:
- Devices like pacemakers, drug delivery implants, and other permanently installed tools that use an internal energy source
Each device must be assigned to a specific category code (e.g., MD 0102 for infusion devices or MD 1302 for vital signs monitors), which must be included in the application.
- Grouping the Medical Device
If a device has multiple models or components, it may be grouped under specific rules. Proper grouping ensures that a single registration covers all relevant components and models.
- Conformity Assessment and Compilation of Technical Documentation
The next step involves conducting a conformity assessment. This process ensures that the device meets the Essential Principles of Safety and Performance as outlined in the Third Schedule of the Medical Device Regulation 2012.
Applicants must:
- Compile evidence of conformity into the Common Submission Dossier Template (CSDT),
- Prepare a Declaration of Conformity using the approved template,
- Appoint a registered Conformity Assessment Body (CAB) to verify the documentation and issue a certificate of conformity.
The CSDT format and contents are specified in the MDA’s guidance documents and must be strictly followed.
- Appointing a CAB
Conformity assessments must be carried out by a registered CAB. The CAB evaluates the technical documentation, verifies compliance with essential safety and performance principles, and issues the relevant certificate and assessment report.
- Submitting the Registration Application via MeDC@St
Once all documentation is complete and verified by a Malaysian CAB, the applicant can submit the registration via MeDC@St. This web-based system serves as the official platform for all device registration activities.
Applicants must first create a MeDC@St account. Once logged in, they can initiate a new application form, which is divided into eight main parts:
- General information
- Manufacturer information
- Grouping details
- CSDT documentation
- Supporting documents for CSDT
- Post-market vigilance history
- Declaration of Conformity
- Attestation for registration
Each section requires specific data and document uploads. Key information includes device classification, intended use, product description, conformity documentation, and any prior market clearances (e.g., from the US FDA or CE Mark).
Key Details Required in the Application
For general information, the applicant must disclose whether the device contains any drug or poison, and confirm its type (general or in-vitro diagnostic). Classification details must be supported by justification in line with regulatory guidelines.
Information about the manufacturer must include address, contact information, and website details. For devices grouped under one application, a list of all constituent models or components must be uploaded.
For sterile or measuring Class A devices, validation reports are required.
Applicants must upload the complete CSDT dossier, including design, risk analysis, clinical evidence (if applicable), manufacturing process, and labeling. Supporting documents and specific elements of the CSDT must be cross-referenced during the submission.
Post-market history must include details of recalls, adverse events, bans in other countries, or rejections by other regulatory authorities.
The Declaration of Conformity should be signed and printed on the manufacturer’s letterhead. The attestation letter must be printed on the establishment’s letterhead, signed, and stamped by the authorized contact person listed in the establishment license.
What Happens After Submission
Upon submission, the MDA reviews the application. If the application is found lacking in information, it may be returned.
Returned applications are flagged in the applicant’s MeDC@St dashboard and accompanied by email notification. The applicant has 90 days to correct and resubmit the application. Failure to do so within the deadline will result in automatic withdrawal of the application, although the applicant may submit a new one at any time.
Reasons for Refusal
The MDA may refuse registration under the following conditions:
- The device does not fulfill the registration requirements
- The product does not meet the legal definition of a medical device
- Incorrect classification of the device
In such cases, the authority will notify the applicant, and a fresh submission may be required if the applicant still seeks registration.
Post-Market Obligations
Even after registration, manufacturers and authorized representatives must monitor the safety and performance of their devices. This includes:
- Reporting adverse events and field safety corrective actions
- Submitting updates or renewals when significant changes are made to the device
- Ensuring proper labeling and usage instructions remain current
Recent Regulatory Update
To support a smoother registration process, the MDA recognizes prior approvals from major regulatory markets, particularly the European Union and the United States. Medical devices that have received CE Marking or hold an EC Declaration of Conformity under EU legislation are considered eligible for Malaysia’s conformity assessment process. These documents can serve as key evidence of compliance during the registration of devices in Malaysia.
In light of the ongoing transition to the European Union’s new Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR), the MDA has issued an important update regarding the acceptance of expired EC certificates. This revision affects both initial registrations and re-registrations for all classes of medical devices and in vitro diagnostic (IVD) devices.
According to the new guidance, expired EC certificates issued under the former directives — Directive 90/385/EEC (Active Implantable Medical Devices), 93/42/EEC (Medical Devices), and 98/79/EC (IVDs) — may still be accepted under specific conditions. These include:
- The device must remain compliant with the relevant EU directive under which it was originally certified.
- There must be no significant changes made to the device’s design.
- The device must not pose any unacceptable risk to users or patients.
In addition to meeting these conditions, manufacturers are required to provide supporting documentation. This may include a confirmation letter from the notified body or a self-declaration letter from the manufacturer affirming continued compliance with the relevant directive and device specifications.
For devices that have already been registered in Malaysia using an EC certificate under the former EU directives, the update does not affect their current approval status. However, when re-registration is due, applicants must either present a valid certificate under the new EU MDR or IVDR, or demonstrate that the three specified conditions continue to be met.
Conclusion
Malaysia’s medical device registration process under Act 737 is detailed and well-structured, aiming to balance patient safety with industry innovation. Manufacturers and representatives seeking to enter the Malaysian market must understand and comply with every stage of the process — from product classification and grouping to documentation and conformity assessment.
With the assistance of registered CABs and a clear application pathway through MeDC@St, stakeholders can effectively navigate the system. However, strict adherence to submission requirements and deadlines is essential to avoid delays, returns, or outright rejection of applications.
Understanding the scope of the regulations and maintaining open communication with the Medical Device Authority will help ensure a smoother registration process and long-term compliance in one of Southeast Asia’s most promising healthcare markets.
Written by: Ames Gross – President and Founder, Pacific Bridge Medical (PBM)
Mr. Gross founded PBM in 1988 and has helped hundreds of medical companies with regulatory and business development issues in Asia. He is recognized nationally and internationally as a leader in the Asian medical markets. Mr. Gross has a BA degree, Phi Beta Kappa, from the University of Pennsylvania and an MBA from Columbia University.